• Subscribe
  • Webinars
  • White Papers
  • Buyer's Guide
  • PhotonicsNXT
  • Get Published!
    • Recent Quotes
    My Watchlist
    Indicators
    BioOptics Stock Watch
    Markets
    Stocks
    ETFs
    Tools
    Markets:
    Overview
    News
    Currencies
    International
    Treasuries

    Alkermes plc - Ordinary Shares (NQ:ALKS)

    32.19 +0.28 (+0.88%)
    Streaming Delayed Price Updated: 4:00 PM EST, Feb 23, 2026 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Price and Volume

    Detailed Quote
    Volume 1,943,664
    Open 31.64
    Bid (Size) 32.20 (100)
    Ask (Size) 32.59 (100)
    Prev. Close 31.91
    Today's Range 31.48 - 32.35
    52wk Range 25.16 - 36.32
    Shares Outstanding 166,121,384
    Dividend Yield N/A
    Chart for (: )
    Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

    Top News

    More News
    News headline image
    From Sizable Stake to Zero: The Likely Reason Why Agios Shares Lost a $94 Million Backer ↗
    Agios Pharmaceuticals develops therapies for rare blood disorders, anchored by its PYRUKYND franchise and early-stage clinical programs. 
    Via The Motley Fool
    News headline image
    Viridian Therapeutics Stock Up 75%, but One Fund Just Sold Off Its $69 Million Stake ↗
    Viridian Therapeutics develops monoclonal antibody therapies targeting rare diseases, with a focus on thyroid eye disease treatments. 
    Via The Motley Fool
    Topics Regulatory Compliance

    Performance

    YTD
    +13.9%
    +13.9%
    1 Month
    -4.2%
    -4.2%
    3 Month
    +14.1%
    +14.1%
    6 Month
    +11.0%
    +11.0%
    1 Year
    -9.4%
    -9.4%

    More News

    Read More
    News headline image
    Spyre Therapeutics Stock Surges This Past Year as $10.5 Million Buy Lifts Stake to $78 Million ↗
    Via The Motley Fool
    Topics Regulatory Compliance
    Race For Avadel Heats Up: Alkermes Raises Offer To Secure $2.37B Deal After Lundbeck Challenge ↗
    Via Stocktwits
    News headline image
    Earnings Scheduled For October 28, 2025 ↗
    Via Benzinga
    News headline image
    Preview: Alkermes's Earnings ↗
    Via Benzinga
    News headline image
    Biotech Fund Dumps 1.85 Million Centessa Shares as Stock Jumps Over 50% ↗
    Via The Motley Fool
    Topics Regulatory Compliance
    News headline image
    Biotech Fund Dumps $84 Million of Nuvalent With Stock Up 29% ↗
    Via The Motley Fool
    Topics Regulatory Compliance
    News headline image
    Alkermes plc Completes Acquisition of Avadel Pharmaceuticals plc, Accelerating Entry Into Sleep Medicine Market
    From Alkermes plc
    Via Business Wire
    News headline image
    Alkermes to Report Fourth Quarter and Year-End Financial Results on Feb. 25, 2026
    From Alkermes plc
    Via Business Wire
    News headline image
    Alixorexton Granted Breakthrough Therapy Designation by U.S. FDA for the Treatment of Narcolepsy Type 1
    From Alkermes plc
    Via Business Wire
    News headline image
    Alkermes to Present at the 44th Annual J.P. Morgan Healthcare Conference
    From Alkermes plc
    Via Business Wire
    News headline image
    Alkermes to Participate in Two Upcoming Investor Conferences
    From Alkermes plc
    Via Business Wire
    News headline image
    Lundbeck's Higher Buyout Proposal Challenges Alkermes' Pending $2 Billion Avadel Deal ↗
    Via Benzinga
    News headline image
    Avadel Surges 20% On Lundbeck's Surprise Alkermes-Topping Bid ↗
    Via Investor's Business Daily
    News headline image
    Avadel Gets Acquisition Proposal From Lundbeck Weeks After Inking Agreement With Alkermes ↗
    Via Stocktwits
    News headline image
    12 Health Care Stocks Moving In Thursday's After-Market Session ↗
    Via Benzinga
    News headline image
    Alkermes Eyes Global Phase 3 Trial After Encouraging Data From Sleep Disorder Study ↗
    Via Benzinga
    News headline image
    This Alkermes Analyst Begins Coverage On A Bullish Note; Here Are Top 3 Initiations For Tuesday ↗
    Via Benzinga
    News headline image
    ALKERMES PLC (NASDAQ:ALKS) Q3 2025 Earnings Beat Estimates and Drive Stock Surge ↗
    Via Chartmill
    Topics Earnings
    News headline image
    Deal Dispatch: From Four Roses Bourbon To Quantum Stakes, Here Are This Week's Sector Shake Ups ↗
    Via Benzinga
    Topics Government
    News headline image
    Breaking Down Alkermes: 8 Analysts Share Their Views ↗
    Via Benzinga
    News headline image
    Alkermes Strikes $2.1 Billion Avadel Deal, Gains Access To Narcolepsy Drug Lumryz ↗
    Via Benzinga
    News headline image
    Avadel Pharmaceuticals Soars as Alkermes Announces $2.1 Billion Acquisition
    Via MarketMinute
    Topics Intellectual Property
    News headline image
    BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Avadel Pharmaceuticals plc (Nasdaq – AVDL), Middlefield Banc Corp. (Nasdaq – MBCN), Heidrick & Struggles International, Inc. (Nasdaq - HSII), Comerica Incorporated
    From Brodsky & Smith LLC
    Via GlobeNewswire

    Frequently Asked Questions

    Is Alkermes plc - Ordinary Shares publicly traded?
    Yes, Alkermes plc - Ordinary Shares is publicly traded.
    What exchange does Alkermes plc - Ordinary Shares trade on?
    Alkermes plc - Ordinary Shares trades on the Nasdaq Stock Market
    What is the ticker symbol for Alkermes plc - Ordinary Shares?
    The ticker symbol for Alkermes plc - Ordinary Shares is ALKS on the Nasdaq Stock Market
    What is the current price of Alkermes plc - Ordinary Shares?
    The current price of Alkermes plc - Ordinary Shares is 32.19
    When was Alkermes plc - Ordinary Shares last traded?
    The last trade of Alkermes plc - Ordinary Shares was at 02/23/26 04:00 PM ET
    What is the market capitalization of Alkermes plc - Ordinary Shares?
    The market capitalization of Alkermes plc - Ordinary Shares is 5.35B
    How many shares of Alkermes plc - Ordinary Shares are outstanding?
    Alkermes plc - Ordinary Shares has 5B shares outstanding.
    Stock Quote API & Stock News API supplied by www.cloudquote.io
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the Privacy Policy and Terms Of Service.
    © 2025 FinancialContent. All rights reserved.